Results 1 to 10 of about 23,252 (297)

Secukinumab-Induced Lymphocytic Colitis [PDF]

open access: yesJournal of Investigative Medicine High Impact Case Reports, 2022
Secukinumab an interleukin-17 (IL-17) monoclonal antibody inhibitor is currently approved for the treatment of rheumatological conditions, such as psoriasis and ankylosing spondylitis.
Siva Santosh Kumar Gandu MD   +3 more
doaj   +4 more sources

Lymphocytic interstitial pneumonia in a patient with lymphocytic colitis [PDF]

open access: yesGastroenterology Review, 2022
The course of lymphocytic colitis (LC) is usually mild with periods of exacerbation and remission. Chronic non-bloody diarrhoea [1] dominates. In recent years significant findings with respect to the association of the gut intraepithelial lymphocytes ...
Cezary Chojnacki   +3 more
doaj   +4 more sources

Evaluation of Melatonin Secretion and Metabolism Exponents in Patients with Ulcerative and Lymphocytic Colitis [PDF]

open access: yesMolecules, 2018
Inflammatory bowel diseases, particularly ulcerative colitis (UC) and lymphocytic colitis (LC), affect many people. The role of melatonin in the pathogenesis of UC is precisely determined, whereas in LC it remains unknown.
Janusz Błasiak   +2 more
exaly   +4 more sources

Lymphocytic colitis can be transcriptionally divided into channelopathic and inflammatory lymphocytic colitis [PDF]

open access: yesUnited European Gastroenterology Journal
AbstractBackgroundThe pathobiology of the non‐destructive inflammatory bowel disease (IBD) lymphocytic colitis (LC) is poorly understood. We aimed to define an LC‐specific mucosal transcriptome to gain insight into LC pathology, identify unique genomic signatures, and uncover potentially druggable disease pathways.MethodsWe performed bulk RNA ...
Andreas Münch   +2 more
exaly   +6 more sources

Lymphocytic colitis in the course of a treatment with sertraline. A case report [PDF]

open access: yesEuropean Psychiatry, 2022
Introduction Lymphocytic colitis is an unusual side-effect of the treatment with SSRIs particularly sertraline. According to several sources, this side effect could be underdiagnosed and underreported.
A. Cerame   +3 more
doaj   +2 more sources

Collagenous and Lymphocytic Colitis: A Clinical and Histopathological Review

open access: yesCanadian Journal of Gastroenterology and Hepatology, 2000
Collagenous colitis and lymphocytic colitis are newly described colitides that are only diagnosable microscopically; therefore, both are known under the umbrella term ’microscopic colitis’.
Curt Tysk
exaly   +2 more sources

Lymphocytic Colitis in Nigeria: A Case Series

open access: yesThe Annals of African Surgery, 2021
The term “microscopic colitis” (MC) is used to describe a chronic inflammatory bowel disease that includes two main subtypes based on histopathologic features: collagenous and lymphocytic.
Aderemi Oluyemi   +3 more
doaj   +1 more source

Analysis of Clinical and Histopathological Findings in Microscopic Colitis

open access: yesTürk Patoloji Dergisi, 2022
Objective: Microscopic colitis is a chronic inflammatory disorder characterized by a triad of chronic diarrhea, endoscopy without significant abnormality, and distinct histopathological features. Histopathologically, microscopic colitis is divided into 3
Gozde TOPEL   +4 more
doaj   +1 more source

Combinations of idelalisib with rituximab and/or bendamustine in patients with recurrent indolent non-Hodgkin lymphoma [PDF]

open access: yes, 2016
Key Points Combining phosphatidylinositol-3-kinase δ inhibition with rituximab, bendamustine, or both is feasible and active in relapsed iNHL.
Barrientos, Jacqueline C.   +14 more
core   +2 more sources

Clinical characteristics and patterns and predictors of response to therapy in collagenous and lymphocytic colitis [PDF]

open access: yesScandinavian Journal of Gastroenterology, 2015
Gregory Lauwers   +2 more
exaly   +2 more sources

Home - About - Disclaimer - Privacy